|
EP1361433A3
(en)
*
|
2002-04-09 |
2005-02-23 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
|
|
US20040191782A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Yixin Wang |
Colorectal cancer prognostics
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
CA2575986A1
(en)
*
|
2004-08-02 |
2006-02-09 |
Banyu Pharmaceutical Co., Ltd. |
Method of assuming drug sensitivity to cdk4 inhibitor
|
|
WO2006060653A2
(en)
*
|
2004-11-30 |
2006-06-08 |
Veridex Llc |
Lung cancer prognostics
|
|
KR100690250B1
(ko)
*
|
2005-01-31 |
2007-03-12 |
디지탈 지노믹스(주) |
폐암 진단용 마커
|
|
US7871774B2
(en)
|
2005-01-31 |
2011-01-18 |
Digital Genomics Inc. |
Markers for the diagnosis of lung cancer
|
|
US20070037186A1
(en)
|
2005-05-20 |
2007-02-15 |
Yuqiu Jiang |
Thyroid fine needle aspiration molecular assay
|
|
IL177006A0
(en)
|
2005-08-02 |
2006-12-10 |
Veridex Llc |
Predicting bone relapse of breast cancer
|
|
US20070130694A1
(en)
*
|
2005-12-12 |
2007-06-14 |
Michaels Emily W |
Textile surface modification composition
|
|
US20070207467A1
(en)
|
2006-03-01 |
2007-09-06 |
Ming Xu |
Detection of lymph node metastasis from gastric carcinoma
|
|
JP2009528825A
(ja)
*
|
2006-03-03 |
2009-08-13 |
ベリデックス・エルエルシー |
デュークスｂ大腸がんの再発を予測するための分子的解析
|
|
US8338109B2
(en)
|
2006-11-02 |
2012-12-25 |
Mayo Foundation For Medical Education And Research |
Predicting cancer outcome
|
|
US20080306881A1
(en)
*
|
2006-12-22 |
2008-12-11 |
X-Shares Advisors Llc |
Portfolio selection for custom indices of public securities based on state of domicile of issuing company
|
|
ES2412432T3
(es)
|
2007-02-27 |
2013-07-11 |
Nuclea Biomarkers Llc |
Método para predecir la respuesta de pacientes de nsclc al tratamiento mediante un inhibidor de egfr-tk
|
|
KR20100120657A
(ko)
*
|
2008-01-22 |
2010-11-16 |
베리덱스, 엘엘씨 |
Ⅱ기 및 ⅲ기 결장암의 분자적 병기 및 예후
|
|
EP2271775A4
(en)
|
2008-04-08 |
2011-09-07 |
Nuclea Biomarkers Llc |
BIOMARKERGROUP FOR PREDICTING THE REPRESENTATION OF COLORECTAL CARCINOMA
|
|
EP2806054A1
(en)
|
2008-05-28 |
2014-11-26 |
Genomedx Biosciences Inc. |
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
|
US10407731B2
(en)
|
2008-05-30 |
2019-09-10 |
Mayo Foundation For Medical Education And Research |
Biomarker panels for predicting prostate cancer outcomes
|
|
GB2463401B
(en)
|
2008-11-12 |
2014-01-29 |
Caris Life Sciences Luxembourg Holdings S A R L |
Characterizing prostate disorders by analysis of microvesicles
|
|
US10236078B2
(en)
|
2008-11-17 |
2019-03-19 |
Veracyte, Inc. |
Methods for processing or analyzing a sample of thyroid tissue
|
|
US9495515B1
(en)
|
2009-12-09 |
2016-11-15 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
|
US9074258B2
(en)
|
2009-03-04 |
2015-07-07 |
Genomedx Biosciences Inc. |
Compositions and methods for classifying thyroid nodule disease
|
|
WO2010124372A1
(en)
|
2009-04-29 |
2010-11-04 |
Genomedx Biosciences, Inc. |
Systems and methods for expression-based classification of thyroid tissue
|
|
US8669057B2
(en)
|
2009-05-07 |
2014-03-11 |
Veracyte, Inc. |
Methods and compositions for diagnosis of thyroid conditions
|
|
US10446272B2
(en)
|
2009-12-09 |
2019-10-15 |
Veracyte, Inc. |
Methods and compositions for classification of samples
|
|
US9128101B2
(en)
|
2010-03-01 |
2015-09-08 |
Caris Life Sciences Switzerland Holdings Gmbh |
Biomarkers for theranostics
|
|
US9469876B2
(en)
|
2010-04-06 |
2016-10-18 |
Caris Life Sciences Switzerland Holdings Gmbh |
Circulating biomarkers for metastatic prostate cancer
|
|
US20130267443A1
(en)
|
2010-11-19 |
2013-10-10 |
The Regents Of The University Of Michigan |
ncRNA AND USES THEREOF
|
|
EP2791359B1
(en)
|
2011-12-13 |
2020-01-15 |
Decipher Biosciences, Inc. |
Cancer diagnostics using non-coding transcripts
|
|
CA2881627A1
(en)
|
2012-08-16 |
2014-02-20 |
Genomedx Biosciences Inc. |
Cancer diagnostics using biomarkers
|
|
US11976329B2
(en)
|
2013-03-15 |
2024-05-07 |
Veracyte, Inc. |
Methods and systems for detecting usual interstitial pneumonia
|
|
US12297505B2
(en)
|
2014-07-14 |
2025-05-13 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
|
US20170335396A1
(en)
|
2014-11-05 |
2017-11-23 |
Veracyte, Inc. |
Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
|
|
AU2017315425B2
(en)
|
2016-08-24 |
2023-11-09 |
The Regents Of The University Of Michigan |
Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
|
|
EP3571322B9
(en)
|
2017-01-20 |
2023-10-04 |
VERACYTE SD, Inc. |
Molecular subtyping, prognosis, and treatment of bladder cancer
|
|
EP3593140A4
(en)
|
2017-03-09 |
2021-01-06 |
Decipher Biosciences, Inc. |
Subtyping prostate cancer to predict response to hormone therapy
|
|
US11078542B2
(en)
|
2017-05-12 |
2021-08-03 |
Decipher Biosciences, Inc. |
Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
|
|
US11217329B1
(en)
|
2017-06-23 |
2022-01-04 |
Veracyte, Inc. |
Methods and systems for determining biological sample integrity
|